Certainly, future studies are needed to investigate whether increased NfL in SLE during follow-up reflects disease activity over time, as well as neuronal damage and future cognitive decline, and if normalization of NfL-concentrations through treatment results in prevention of this outcome. This evidence concerns the gene NEFL and systemic lupus erythematosus.